These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16194652)

  • 1. Reversal of a potent investigational anticoagulant: idraparinux with recombinant factor VIIa.
    Dao A; Tuan B; Carlson N
    Am J Med; 2005 Oct; 118(10):1172-3. PubMed ID: 16194652
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB.
    Courtney H
    Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650
    [No Abstract]   [Full Text] [Related]  

  • 3. Traumatic hemoptysis treated with recombinant human factor VIIa.
    O'Connor JV; Stein DM; Dutton RP; Scalea TM
    Ann Thorac Surg; 2006 Apr; 81(4):1485-7. PubMed ID: 16564298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood coagulation self management facilitates anticoagulant therapy. Reduces risk of complications and mortality].
    MMW Fortschr Med; 2010 Sep; 152(38):44-5. PubMed ID: 20957788
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy.
    Sanchis Cervera J; Andrés Blasco CJ; Mena-Duran AV
    Acta Haematol; 2003; 110(1):51-2. PubMed ID: 12975561
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant factor VIIa treatment for life-threatening haemoptysis.
    Yildirim H; Ucgun I; Yalcin AU; Gulbaş Z; Sahin G; Acikalin MF; Metintas M; Ak G
    Respirology; 2006 Sep; 11(5):652-4. PubMed ID: 16916342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of recombinant activated factor vii in bronchoalveolar lavage in a case of pulmonary hemorrhage].
    Rodríguez-Serrano DA; Leal-Micharet A; Rajas O; Chicot-Llano M; García-Romero de Tejada JA
    Med Intensiva; 2015 May; 39(4):253-5. PubMed ID: 25192918
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant factor VIIa in severe uremic bleeding.
    Révész T; Arets B; Bierings M; van den Bos C; Duval E
    Thromb Haemost; 1998 Aug; 80(2):353. PubMed ID: 9716175
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery.
    Morante L; Guasch EV; Palacio F; Gilsanz F
    Anesth Analg; 2006 Jun; 102(6):1902-3. PubMed ID: 16717350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulation in the elderly--a thin line between benefit and risk].
    Steffel J; Lüscher TF
    MMW Fortschr Med; 2009 Apr; 151(16):33-6. PubMed ID: 19658293
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bleeding associated with septic shock treated successfully with recombinant activated factor VII: a case report].
    Del Cojo Peces E; Torrado Criado MD; Macías Pingarrón JP; Negrete Calderón N
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):301-3. PubMed ID: 15968911
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
    De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
    Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractoriness.
    Culligan DJ; Salamat A; Tait J; Westland G; Watson HG
    Bone Marrow Transplant; 2003 Jun; 31(12):1183-4. PubMed ID: 12796803
    [No Abstract]   [Full Text] [Related]  

  • 14. Intentional overdose of warfarin in an adult: anticoagulant reversal in the ED.
    Matthews SS; Ringeisen AL; Wedro B
    Am J Emerg Med; 2014 Sep; 32(9):1150.e1-2. PubMed ID: 24674108
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.
    Wheater MJ; Mead GM; Bhandari S; Fennell J
    J Clin Oncol; 2008 Feb; 26(6):1008-10. PubMed ID: 18281675
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant.
    Cetin H; Yalaz M; Akisu M; Karapinar DY; Kavakli K; Kultursay N
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):213-6. PubMed ID: 16575260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa.
    Filan PM; Mills JF; Clarnette TD; Ekert H; Ekert P
    J Pediatr; 2005 Dec; 147(6):857-9. PubMed ID: 16356448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).
    Kositchaiwat C; Chuansumrit A
    Thromb Haemost; 2001 Oct; 86(4):1125-6. PubMed ID: 11686340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alveolar hemorrhage secondary to generalized systemic lupus erithematosus treated with recombinant activated factor VII. Case report and literature review].
    Carrillo-Esper R; Elizondo-Argueta S; Sánchez-Zúñiga Mde J; Carrillo-Córdova JR
    Gac Med Mex; 2007; 143(1):83-6. PubMed ID: 17388100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.